Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion type Assertion NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_head.
- NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion description "[The expression of TUBB3 gene was obviously higher in NSCLC patients in phases I/II and IV than those in phase III (P1=0.021; P2=0.004), and it was also markedly higher in patients without lymph node metastasis than those with (P=0.008).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_provenance.
- NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion evidence source_evidence_literature NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_provenance.
- NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion SIO_000772 25921119 NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_provenance.
- NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion wasDerivedFrom befree-2016 NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_provenance.
- NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_assertion wasGeneratedBy ECO_0000203 NP1281141.RAIhOOK4Mw2ZlxKxuPyslhHDoTSoLCSJ5rzqI0E63tKOc130_provenance.